ERBB2 and breast carcinoma: According to all controversies regarding the diagnostic/screening value of serum-HER2 in breast cancer, to overcome this debate, we conducted a meta-analysis to integrate the results of studies included with adequate data for calculation of the test’s accuracy in this regard.